PGTG successfully develops SGF bone-derived factor to restore the skeletal system

Anhui Guotai Biotechnology Co.,Ltd.

PR99115

 

BEIJING, Dec. 7, 2022 /PRNewswire=KYODO JBN/ --

 

The bone-derived skeletal growth factor (SGF), jointly developed by a research

facility under the direction of leading biochemist, academician and researcher

Zhao Yufen and the Anhui-based research center of one of the world's health

industry leaders People's GuoTai Group (PGTG), broke through the formula

stability bottleneck after unremitting efforts over the last three years and

brought new hope for bone health. It is the world's only healthcare supplement

that provides protection against diseases of the skeletal system, and the only

dietary health product that can supplement calcium without side effects,

improve bone density, strengthen bones, lubricate bone joints and regenerate

cartilage.

 

The GuoTai SGF bone-derived factor is the first to resolve the stability issue,

and was finally released after tens of thousands of iterations until just the

right formulation was achieved: a finely-tuned combination of PGTG's patented

small molecule yak bone collagen peptide to add to bone density and strengthen

the bone, PGTG's patented cartilage peptide for bone joint lubrication, and

chitosan oligosaccharide, a.k.a. the "sixth essential element of the body", to

promote cartilage regeneration, as well as milk mineral salts that further

enhance bone density. It is the only integrated product in the world that can

simultaneously offer everything that is needed for bone health in one

formulation: supplement calcium, improve bone density, strengthen the bone,

lubricate the joints, and regenerate cartilage.

 

With several features proprietary to PGTG, the GuoTai SGF bone-derived factor

can regulate bone metabolism and promote bone growth. The superior product is a

result of PGTG's three years of work and has delivered a formulation that, for

the first time, includes just the right combination of chitosan

oligosaccharide, yak bone peptide and milk mineral salt and maintains full

stability after tens of thousands of tests.

 

 

SOURCE: Anhui Guotai Biotechnology Co.,Ltd.

本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。

このプレスリリースには、報道機関向けの情報があります。

プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。

プレスリリース受信に関するご案内

SNSでも最新のプレスリリース情報をいち早く配信中